Aldeyra Therapeutics Announces Statistically and Clinically

Statistically significant improvement from baseline observed in investigator-assessed Eczema Area and Severity Index and Investigator Global Assessment



EASI 75% improvement threshold observed...

Related Keywords

United States , Matthew Zirwas , Securities Exchange , Aldeyra Therapeutics Inc , Nasdaq , Exchange Commission , Bexley Dermatology Research , Aldeyra Therapeutics , Principal Investigator , Eczema Area , Severity Index , Investigator Global Assessment , Patient Oriented Eczema Measure , Peak Pruritus Numerical Rating Scale , Hamilton Depression Rating Scale , Beck Anxiety Inventory , Conference Call , Investor Relations , Private Securities Litigation Reform Act , Securities Exchange Act , Financial Condition , Annual Report , Quarterly Report , Markets ,